Effect of vanillin and ethyl vanillin on cytochrome P450 activity in vitro and in vivo

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 1897-1901

  Chen, Xiao min ^b   Wei, Min ^a   Zhang, Hai mou ^b   Luo, Cheng hao ^a   Chen, Yi kun ^a   Chen, Yong ^b  

^a Technology Center of China Tobacco Hubei Industry Limited Liability Company   (China)

^b HUBEI UNIVERSITY   (China)

Author keywords

Cytochrome P450; Enzyme activity; Ethyl vanillin; Liver microsome; Vanillin

Indexed keywords

3 ETHOXY 4 HYDROXYBENZALDEHYDE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2C; CYTOCHROME P450 2C9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; UNCLASSIFIED DRUG; VANILLIN; VANILLIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SPECIFICITY; FOOD SAFETY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER MICROSOME; MOLECULAR INTERACTION; NONHUMAN; RAT;

ANIMALS; ANTIOXIDANTS; BENZALDEHYDES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; INDICATORS AND REAGENTS; ISOENZYMES; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

RATTUS;

EID: 84860152554     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.03.060     Document Type: Article

References (23)

1. Allis J.W., Robinson B.L. A kinetic assay for p-nitrophenol hydroxylase in rat liver microsomes. Anal. Biochem. 1994, 219:49-52.
2. Bjornsson T.D., Callaghan J.T., Einolf H.J., Fischer V., Gan L., Grimm S., Kao J., King S.P., Miwa G., Ni L., Kumar G., McLeod J., Obach R.S., Roberts S., Roe A., Shah A., Snikeris F., Sullivan J.T., Tweedie D., Vega J.M., Walsh J., Wrighton S.A. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab. Dispos. 2003, 31:815-832.
3. Bogaards J.J., Bertrand M., Jackson P., Oudshoorn M.J., Weaver R.J., van Bladeren P.J., Walther B. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000, 30:1131-1152.
4. Cao X.Z., Zhang W., Yao Z.H., Tan Z.R., Zhou H.H., Yao X.S. Effect of methyl protodioscin on seven cytochrome P450s activity in human microsomes. J. Shenyang Pharm. Univ. 2008, 11:914-918.
5. Gonzalez F.J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 2005, 569:101-110.
6. Guengerich F.P. Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 1997, 43:7-35.
7. Guengerich F.P. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 2006, 8:101-111.
8. Gunes A., Dahl M.L. Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 2008, 9:625-637.
9. Guo Y., Wang H. Study of probe substrate specificity for human cytochrome P450 isoenzymes. Chin. Pharmacol. Bull. 2007, 23:851-854.
10. Ho K., Yazan L.S., Ismail N., Ismail M. Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin. Cancer Epidemiol. 2009, 33:155-160.
11. Ho K., Yazan L.S., Ismail N., Ismail M. Toxicology study of vanillin on rats via oral and intra-peritoneal administration. Food Chem. Toxicol. 2011, 49:25-30.
12. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2002. Evaluation of Certain Food Additives and Contaminants: Fifty-Seventh Report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization, Geneva (read at: <>). http://www.whqlibdoc.who.int/trs/WHO_TRS_909.pdf.
13. Jurica J., Konecny J., Zahradnikova L.Z., Tomandl J. Simultaneous HPLC determination of tolbutamide, phenacetin and their metabolites as markers of cytochromes 1A2 and 2C6/11 in rat liver perfusate. J. Pharm. Biomed. Anal. 2010, 52:557-564.
14. Ko J.W., Desta Z., Flockhart D.A. Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metab. Dispos. 1998, 26:775-778.
15. Peng Z.H., Song W., Han F.M., Chen Y. In vivo and in vitro study of papaverine and its major metabolites. Yao Xue Xue Bao 2009, 44:95-100.
16. Qiu F.R., Zhang R., Sun J.G., Wang G.J., Jiang J., Ma Y.M. Determination of 6β-hydroxytestosterone and 1-hydroxymidazolam in human liver microsomes by HPLC. Chin. J. Clin. Pharm. 2010, 19:145-148.
17. Relling M.V., Aoyama T., Gonzalez F.J., Meyer U.A. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J. Pharmacol. Exp. Ther. 1990, 252:442-447.
18. Rupasinghe H.P.Vasantha., Boulter-Bitzer Jeanine., Ahn Taehyun., Odumeru Joseph.A. Vanillin inhibits pathogenic and spoilage microorganisms in vitro and aerobic microbial growth in fresh-cut apples. Food Res. Int. 2005, 39:575-580.
19. Sarich T.C., Adams S.P., Petricca G., Wright J.M. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. J. Pharmacol. Exp. Ther. 1999, 289:695-702.
20. Sasaki Y.F., Ohta T., Imanishi H., Watanabe M., Matsumoto K., Kato T., Shirasu Y. Suppressing effects of vanillin, cinnamaldehyde, and anisaldehyde on chromosome aberrations induced by X-rays in mice. Mutat. Res. 1990, 243:299-302.
21. Tai A., Sawano T., Yazama F., Ito H. Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochim. Biophys. Acta 2011, 1810:170-177.
22. Yao H.T., Lin P., Chang Y.W., Chen C.T., Chiang M.T., Chang L., Kuo Y.C., Tsai H.T., Yeh T.K. Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes. Food Chem. Toxicol. 2009, 47:1703-1709.
23. Zhang C., Li X., Lian L., Chen G., Abdulmalik O., Vassilev V., Lai C., Asakura T. Anti-sickling effect of MX-1520, a prodrug of vanillin: an in vivo study sing rodent. Br. J. Haematol. 2004, 125:788-795.